1. Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy 
Matthew Mossanen, Kenneth G. Nepple, Robert L. Grubb, Gerald L. Androile, Dorina Kallogjeri, Eric A. Klein, Andrew J. Stephenson, Adam S. Kibel 
European Urology Oncology 
Volume 1, Issue 2, Pages (June 2018)
DOI: /j.euo
Copyright © 2018 European Association of Urology Terms and Conditions

2. Fig. 1
Prostate cancer–specific survival according to the Kaplan-Meier method for different definitions of high-risk prostate cancer treated with radical prostatectomy (RP). PSA=prostate-specific antigen; NCCN=National Comprehensive Cancer Network; RFS=recurrence-free survival.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions

3. Fig. 2
Overall survival according to the Kaplan-Meier method for different definitions of high-risk prostate cancer treated with radical prostatectomy (RP). PSA=prostate-specific antigen; NCCN=National Comprehensive Cancer Network; RFS=recurrence-free survival.
European Urology Oncology 2018 1, DOI: ( /j.euo )
Copyright © 2018 European Association of Urology Terms and Conditions